First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors GBX 1,695.74 +6.94 (+0.41%) As of 10/15/2025 03:15 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock FBT vs. PRSM, KAPE, KNOS, TRST, LTG, ALFA, GBG, IMO, NCC, and CERShould you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include Blue Prism Group (PRSM), Kape Technologies (KAPE), Kainos Group (KNOS), Trustpilot Group (TRST), Learning Technologies Group (LTG), Alfa Financial Software (ALFA), GB Group (GBG), IMImobile (IMO), NCC Group (NCC), and Cerillion (CER). These companies are all part of the "software - application" industry. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs. Its Competitors Blue Prism Group Kape Technologies Kainos Group Trustpilot Group Learning Technologies Group Alfa Financial Software GB Group IMImobile NCC Group Cerillion Blue Prism Group (LON:PRSM) and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk. Is PRSM or FBT more profitable? Company Net Margins Return on Equity Return on Assets Blue Prism GroupN/A N/A N/A First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation N/A N/A N/A Which has better earnings & valuation, PRSM or FBT? First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Blue Prism Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBlue Prism Group£167.30M0.00N/A-£53.80N/AFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10-1,541.59 Does the media favor PRSM or FBT? In the previous week, Blue Prism Group's average media sentiment score of 0.00 equaled First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation'saverage media sentiment score. Company Overall Sentiment Blue Prism Group Neutral First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Neutral SummaryBlue Prism Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 2 of the 3 factors compared between the two stocks. Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBT vs. The Competition Export to ExcelMetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON ExchangeMarket Cap£695.62M£7.37B£32.38B£2.58BDividend YieldN/A3.74%3.20%5.32%P/E Ratio-1,541.591,309.92494.834,411.10Price / SalesN/A248.261,520.80100,849.40Price / Cash3.5417.3337.7927.90Price / BookN/A10.397.768.25Net IncomeN/A£49.83M£820.59M£5.89B7 Day Performance-1.59%0.70%0.18%-0.12%1 Month Performance7.36%-0.40%6.50%2.33%1 Year Performance5.08%3.94%23,961.12%139.17% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBTFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AGBX 1,695.74+0.4%N/A+5.1%£695.62MN/A-1,541.5920PRSMBlue Prism GroupN/AN/AN/AN/A£1.24B£167.30M-23.681,025High Trading VolumeKAPEKape TechnologiesN/AN/AN/AN/A£1.22B£623.48M1,900.00850Gap DownKNOSKainos Group1.1118 of 5 starsGBX 960.58-1.1%GBX 1,041.67+8.4%+18.2%£1.15B£367.25M3,406.312,953TRSTTrustpilot Group2.2563 of 5 starsGBX 215+0.8%GBX 340.75+58.5%-7.0%£866.61M£233.80M-181.43820Positive NewsHigh Trading VolumeLTGLearning Technologies GroupN/AN/AN/AN/A£792.10M£529.20M16.755,001ALFAAlfa Financial Software1.4812 of 5 starsGBX 233+0.2%GBX 276+18.5%+13.6%£688.37M£120.10M2,351.16475GBGGB Group2.8923 of 5 starsGBX 250.25-0.3%GBX 390+55.8%-16.5%£614.00M£282.72M7,360.291,183News CoverageIMOIMImobileN/AN/AN/AN/A£490.40M£164.04M123.755,300NCCNCC Group1.7281 of 5 starsGBX 145.40-0.3%GBX 175+20.4%-13.2%£446.80M£324.40M-1,817.502,200Dividend CutHigh Trading VolumeCERCerillionN/AGBX 1,520+0.7%GBX 2,350+54.6%-14.6%£445.46M£42.15M3,160.08321Dividend Increase Related Companies and Tools Related Companies Blue Prism Group Competitors Kape Technologies Competitors Kainos Group Competitors Trustpilot Group Competitors Learning Technologies Group Competitors Alfa Financial Software Competitors GB Group Competitors IMImobile Competitors NCC Group Competitors Cerillion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FBT) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
